Michael Kolinsky

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

Cora N. Sternberg, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2020 · 422 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

Se Hoon Park, Jeffrey C. Goh, Sang Joon Shin et al. · Journal of Clinical Oncology · 2023 · 132 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study

Joaquı́n Mateo, Heather H. Cheng, Himisha Beltran et al. · European Urology · 2018 · 120 citations · Full text

Medicine, Oncology, Urology +15

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

Michael Kolinsky, Pasquale Rescigno, Diletta Bianchini et al. · Annals of Oncology · 2020 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer

Adam Sharp, Jon Welti, Maryou B. Lambros et al. · European Urology · 2019 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +17